Health Care–Acquired Viral Respiratory Diseases

Infectious Disease Clinics of North America

Volumn 30, Issue 4, 2016, Pages 1053-1070

  Dare, Ryan K ^a   Talbot, Thomas R ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Health care acquired infection; Influenza; Middle East respiratory syndrome; Nosocomial infection; Respiratory syncytial virus

Indexed keywords

INFLUENZA VACCINE;

ADENOVIRUS INFECTION; CORONAVIRIDAE INFECTION; HAND WASHING; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; NONHUMAN; PANDEMIC INFLUENZA; PARAINFLUENZA VIRUS INFECTION; PATIENT EDUCATION; PATIENT ISOLATION; PROTECTIVE EQUIPMENT; REVIEW; SEASONAL INFLUENZA; VIRAL RESPIRATORY TRACT INFECTION; VIRUS TRANSMISSION; CORONAVIRUS INFECTION; CROSS INFECTION; RESPIRATORY TRACT INFECTION; VIRUS INFECTION;

CORONAVIRUS INFECTIONS; CROSS INFECTION; HUMANS; INFLUENZA, HUMAN; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES;

EID: 84995479975     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2016.07.004     Document Type: Review

References (118)

1. 1 Hall, C.B., Nosocomial viral respiratory infections: perennial weeds on pediatric wards. Am J Med 70 (1981), 670–676.
2. 2 Tablan, O.C., Anderson, L.J., Besser, R., et al. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 53 (2004), 1–36.
3. 3 Shay, D.K., Holman, R.C., Newman, R.D., et al. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 282 (1999), 1440–1446.
4. 4 Falsey, A.R., Hennessey, P.A., Formica, M.A., et al. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 352 (2005), 1749–1759.
5. 5 Goldstein, E., Greene, S.K., Olson, D.R., et al. Estimating the hospitalization burden associated with influenza and respiratory syncytial virus in New York City, 2003-2011. Influenza Other Respir Viruses 9 (2015), 225–233.
6. 6 Hall, C.B., Douglas, R.G. Jr., Geiman, J.M., et al. Nosocomial respiratory syncytial virus infections. N Engl J Med 293 (1975), 1343–1346.
7. 7 Halasa, N.B., Williams, J.V., Wilson, G.J., et al. Medical and economic impact of a respiratory syncytial virus outbreak in a neonatal intensive care unit. Pediatr Infect Dis J 24 (2005), 1040–1044.
8. 8 Englund, J.A., Anderson, L.J., Rhame, F.S., Nosocomial transmission of respiratory syncytial virus in immunocompromised adults. J Clin Microbiol 29 (1991), 115–119.
9. 9 Mathur, U., Bentley, D.W., Hall, C.B., Concurrent respiratory syncytial virus and influenza A infections in the institutionalized elderly and chronically ill. Ann Intern Med 93 (1980), 49–52.
10. 10 French, C.E., McKenzie, B.C., Coope, C., et al. Risk of nosocomial respiratory syncytial virus infection and effectiveness of control measures to prevent transmission events: a systematic review. Influenza Other Respir Viruses 10:4 (2016), 268–290.
11. 11 Hall, C.B., Geiman, J.M., Douglas, R.G. Jr., et al. Control of nosocomial respiratory syncytial viral infections. Pediatrics 62 (1978), 728–732.
12. 12 Hall, C.B., Kopelman, A.E., Douglas, R.G. Jr., et al. Neonatal respiratory syncytial virus infection. N Engl J Med 300 (1979), 393–396.
13. 13 Hall, C.B., Nosocomial respiratory syncytial virus infections: the “Cold War” has not ended. Clin Infect Dis 31 (2000), 590–596.
14. 14 Jena, A.B., Baldwin, D.C. Jr., Daugherty, S.R., et al. Presenteeism among resident physicians. JAMA 304 (2010), 1166–1168.
15. 15 Jena, A.B., Meltzer, D.O., Press, V.G., et al. Why physicians work when sick. Arch Intern Med 172 (2012), 1107–1108.
16. 16 Hall, C.B., Douglas, R.G. Jr., Schnabel, K.C., et al. Infectivity of respiratory syncytial virus by various routes of inoculation. Infect Immun 33 (1981), 779–783.
17. 17 Hall, C.B., Douglas, R.G. Jr., Modes of transmission of respiratory syncytial virus. J Pediatr 99 (1981), 100–103.
18. 18 Hall, C.B., Douglas, R.G. Jr., Geiman, J.M., Possible transmission by fomites of respiratory syncytial virus. J Infect Dis 141 (1980), 98–102.
19. 19 Hall, C.B., Douglas, R.G. Jr., Geiman, J.M., Respiratory syncytial virus infections in infants: quantitation and duration of shedding. J Pediatr 89 (1976), 11–15.
20. 20 Hall, C.B., Douglas, R.G. Jr., Nosocomial respiratory syncytial viral infections. Should gowns and masks be used?. Am J Dis Child 135 (1981), 512–515.
21. 21 Murphy, D., Todd, J.K., Chao, R.K., et al. The use of gowns and masks to control respiratory illness in pediatric hospital personnel. J Pediatr 99 (1981), 746–750.
22. 22 Leclair, J.M., Freeman, J., Sullivan, B.F., et al. Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. N Engl J Med 317 (1987), 329–334.
23. 23 Langley, J.M., LeBlanc, J.C., Wang, E.E., et al. Nosocomial respiratory syncytial virus infection in Canadian pediatric hospitals: a pediatric investigators collaborative network on infections in Canada Study. Pediatrics 100 (1997), 943–946.
24. 24 Gala, C.L., Hall, C.B., Schnabel, K.C., et al. The use of eye-nose goggles to control nosocomial respiratory syncytial virus infection. JAMA 256 (1986), 2706–2708.
25. 25 Agah, R., Cherry, J.D., Garakian, A.J., et al. Respiratory syncytial virus (RSV) infection rate in personnel caring for children with RSV infections. Routine isolation procedure vs routine procedure supplemented by use of masks and goggles. Am J Dis Child 141 (1987), 695–697.
26. 26 Madge, P., Paton, J.Y., McColl, J.H., et al. Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus. Lancet 340 (1992), 1079–1083.
27. 27 Macartney, K.K., Gorelick, M.H., Manning, M.L., et al. Nosocomial respiratory syncytial virus infections: the cost-effectiveness and cost-benefit of infection control. Pediatrics 106 (2000), 520–526.
28. 28 Snydman, D.R., Greer, C., Meissner, H.C., et al. Prevention of nosocomial transmission of respiratory syncytial virus in a newborn nursery. Infect Control Hosp Epidemiol 9 (1988), 105–108.
29. 29 Siegel, J.D., Rhinehart, E., Jackson, M., et al., Health care infection control practices advisory C. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 35 (2007), S65–S164.
30. 30 Karanfil, L.V., Conlon, M., Lykens, K., et al. Reducing the rate of nosocomially transmitted respiratory syncytial virus. Am J Infect Control 27 (1999), 91–96.
31. 31 Krasinski, K., LaCouture, R., Holzman, R.S., et al. Screening for respiratory syncytial virus and assignment to a cohort at admission to reduce nosocomial transmission. J Pediatr 116 (1990), 894–898.
32. 32 Chartrand, C., Tremblay, N., Renaud, C., et al. Diagnostic accuracy of rapid antigen detection tests for respiratory syncytial virus infection: systematic review and meta-analysis. J Clin Microbiol 53 (2015), 3738–3749.
33. 33 Feltes, T.F., Cabalka, A.K., Meissner, H.C., et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr 143 (2003), 532–540.
34. 34 Kurz, H., Herbich, K., Janata, O., et al. Experience with the use of palivizumab together with infection control measures to prevent respiratory syncytial virus outbreaks in neonatal intensive care units. J Hosp Infect 70 (2008), 246–252.
35. 35 American Academy of Pediatrics Committee on Infectious D, American Academy of Pediatrics Bronchiolitis Guidelines C, Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 134 (2014), 415–420.
36. 36 Talbot, T.R., Bradley, S.E., Cosgrove, S.E., et al. Influenza vaccination of healthcare workers and vaccine allocation for healthcare workers during vaccine shortages. Infect Control Hosp Epidemiol 26 (2005), 882–890.
37. 37 Salgado, C.D., Farr, B.M., Hall, K.K., et al. Influenza in the acute hospital setting. Lancet Infect Dis 2 (2002), 145–155.
38. 38 Elder, A.G., O'Donnell, B., McCruden, E.A., et al. Incidence and recall of influenza in a cohort of Glasgow healthcare workers during the 1993-4 epidemic: results of serum testing and questionnaire. BMJ 313 (1996), 1241–1242.
39. 39 Widera, E., Chang, A., Chen, H.L., Presenteeism: a public health hazard. J Gen Intern Med 25 (2010), 1244–1247.
40. 40 Poland, G.A., Tosh, P., Jacobson, R.M., Requiring influenza vaccination for health care workers: seven truths we must accept. Vaccine 23 (2005), 2251–2255.
41. 41 Douglas, R.G. Jr., Influenza in man. Kilbourne, E.D., (eds.) The influenza viruses and influenza, 1975, Academic Press, New York, 395–447.
42. 42 Murphy, B.R., Chalhub, E.G., Nusinoff, S.R., et al. Temperature-sensitive mutants of influenza virus. III. Further characterization of the ts-1[E] influenza A recombinant (H3N2) virus in man. J Infect Dis 128 (1973), 479–487.
43. 43 Hayden, F.G., Fritz, R., Lobo, M.C., et al. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 101 (1998), 643–649.
44. 44 Ip, D.K., Lau, L.L., Chan, K.H., et al. The dynamic relationship between clinical symptomatology and viral shedding in naturally acquired seasonal and pandemic influenza virus infections. Clin Infect Dis 62 (2016), 431–437.
45. 45 Hall, C.B., Douglas, R.G. Jr., Nosocomial influenza infection as a cause of intercurrent fevers in infants. Pediatrics 55 (1975), 673–677.
46. 46 Englund, J.A., Champlin, R.E., Wyde, P.R., et al. Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clin Infect Dis 26 (1998), 1418–1424.
47. 47 Bean, B., Moore, B.M., Sterner, B., et al. Survival of influenza viruses on environmental surfaces. J Infect Dis 146 (1982), 47–51.
48. 48 Boone, S.A., Gerba, C.P., The occurrence of influenza A virus on household and day care center fomites. J Infect 51 (2005), 103–109.
49. 49 Andrewes, C.H., Glover, R.E., Spread of infection from the respiratory tract of the ferret. I. Transmission of influenza A virus. Br J Exp Pathol 22 (1941), 91–97.
50. 50 Schulman, J.L., Kilbourne, E.D., Airborne transmission of influenza virus infection in mice. Nature 195 (1962), 1129–1130.
51. 51 Schulman, J.L., Experimental transmission of influenza virus infection in mice. IV. Relationship of transmissibility of different strains of virus and recovery of airborne virus in the environment of infector mice. J Exp Med 125 (1967), 479–488.
52. 52 Alford, R.H., Kasel, J.A., Gerone, P.J., et al. Human influenza resulting from aerosol inhalation. Proc Soc Exp Biol Med 122 (1966), 800–804.
53. 53 Knight, V., Viruses as agents of airborne contagion. Ann N Y Acad Sci 353 (1980), 147–156.
54. 54 Loudon, R.G., Roberts, R.M., Droplet expulsion from the respiratory tract. Am Rev Respir Dis 95 (1967), 435–442.
55. 55 Papineni, R.S., Rosenthal, F.S., The size distribution of droplets in the exhaled breath of healthy human subjects. J Aerosol Med 10 (1997), 105–116.
56. 56 Blachere, F.M., Lindsley, W.G., Pearce, T.A., et al. Measurement of airborne influenza virus in a hospital emergency department. Clin Infect Dis 48:4 (2009), 438–440.
57. 57 McLean, R.L., International conference on Asian influenza; 1960 February 17-19. 1960, The American Review of Respiratory Diseases, Bethesda (MD), 36–38.
58. 58 Moser, M.R., Bender, T.R., Margolis, H.S., et al. An outbreak of influenza aboard a commercial airliner. Am J Epidemiol 110 (1979), 1–6.
59. 59 Blumenfeld, H.L., Kilbourne, E.D., Louria, D.B., et al. Studies on influenza in the pandemic of 1957-1958. I. An epidemiologic, clinical and serologic investigation of an intrahospital epidemic, with a note on vaccination efficacy. J Clin Invest 38 (1959), 199–212.
60. 60 Bridges, C.B., Kuehnert, M.J., Hall, C.B., Transmission of influenza: implications for control in health care settings. Clin Infect Dis 37 (2003), 1094–1101.
61. 61 Loeb, M., Dafoe, N., Mahony, J., et al. Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. JAMA 302:17 (2009), 1865–1871.
62. 62 Macintyre CR, Wang Q, Cauchemez S, et al. The first randomised, controlled clinical trial of surgical masks compared to fit-tested and non-fit tested N95 masks in the prevention of respiratory virus infection in hospital health care workers in Beijing, China. Presented at the 47th Annual Meeting of the Infectious Diseases Society of America; 2009. Philadelphia. October 31, 2009. p. 40.
63. 63 Centers for Disease Control and Prevention. Prevention Strategies for Seasonal Influenza in Healthcare Settings. Available at: http://www.cdc.gov/flu/professionals/infectioncontrol/healthcaresettings.htm. Accessed May 30, 2016.
64. 64 Blanco, N., Eisenberg, M.C., Stillwell, T., et al. What transmission precautions best control influenza spread in a hospital?. Am J Epidemiol 183:11 (2016), 1045–1054.
65. 65 Fiore, A.E., Shay, D.K., Broder, K., et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 58 (2009), 1–52.
66. 66 Wilde, J.A., McMillan, J.A., Serwint, J., et al. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA 281 (1999), 908–913.
67. 67 Saxen, H., Virtanen, M., Randomized, placebo-controlled double blind study on the efficacy of influenza immunization on absenteeism of health care workers. Pediatr Infect Dis J 18 (1999), 779–783.
68. 68 Feery, B.J., Evered, M.G., Morrison, E.I., Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976. J Infect Dis 139 (1979), 237–241.
69. 69 Vanhems, P., Voirin, N., Roche, S., et al. Risk of influenza-like illness in an acute health care setting during community influenza epidemics in 2004-2005, 2005-2006, and 2006-2007: a prospective study. Arch Intern Med 171 (2011), 151–157.
70. 70 Salgado, C.D., Giannetta, E.T., Hayden, F.G., et al. Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians. Infect Control Hosp Epidemiol 25 (2004), 923–928.
71. 71 Frenzel, E., Chemaly, R.F., Ariza-Heredia, E., et al. Association of increased influenza vaccination in health care workers with a reduction in nosocomial influenza infections in cancer patients. Am J Infect Control, 2016 [Epub ahead of print].
72. 72 Potter, J., Stott, D.J., Roberts, M.A., et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 175 (1997), 1–6.
73. 73 Carman, W.F., Elder, A.G., Wallace, L.A., et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 355 (2000), 93–97.
74. 74 Hayward, A.C., Harling, R., Wetten, S., et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ, 333, 2006, 1241.
75. 75 Lemaitre, M., Meret, T., Rothan-Tondeur, M., et al. Effect of influenza vaccination of nursing home staff on mortality of residents: a cluster-randomized trial. J Am Geriatr Soc 57:9 (2009), 1580–1586.
76. 76 Vaccination coverage estimates from the National Health Interview Survey: United States, 2008. Centers for Disease Control and Prevention. 2009. Available at: http://www.cdc.gov/nchs/data/hestat/vaccine_coverage.htm. Accessed October 8, 2009.
77. 77 Honor roll for patient safety. Mandatory influenza vaccination policies for healthcare workers. Immunization Action Coalition. Available at: http://www.immunize.org/laws/influenzahcw.asp. Accessed November 19, 2009.
78. 78 Health Affairs Blog. The ‘Must Do’ List: Certain patient safety rules should not be elective. Available at: http://healthaffairs.org/blog/2015/08/20/the-must-do-list-certain-patient-safety-rules-should-not-be-elective/. Accessed May 30, 2016.
79. 79 Black, C.L., Yue, X., Ball, S.W., et al. Influenza vaccination coverage among health care personnel—United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep 64 (2015), 993–999.
80. 80 Fiore, A.E., Shay, D.K., Broder, K., et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 57 (2008), 1–60.
81. 81 Harper, S.A., Bradley, J.S., Englund, J.A., et al. Seasonal influenza in adults and children–diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 48 (2009), 1003–1032.
82. 82 Higa, F., Tateyama, M., Tomishima, M., et al. Role of neuraminidase inhibitor chemoprophylaxis in controlling nosocomial influenza: an observational study. Influenza Other Respir Viruses 6 (2012), 299–303.
83. 83 Steininger, C., Kundi, M., Aberle, S.W., et al. Effectiveness of reverse transcription-PCR, virus isolation, and enzyme-linked immunosorbent assay for diagnosis of influenza A virus infection in different age groups. J Clin Microbiol 40 (2002), 2051–2056.
84. 84 H5N1 avian influenza: timeline of major events, March 23, 2009. World Health Organization. 2009. Available at: http://www.who.int/csr/disease/avian_influenza/Timeline_09_03_23.pdf. Accessed July 27, 2009.
85. 85 Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO, September 24, 2009. World Health Organization. 2009. Available at: http://www.who.int/csr/disease/avian_influenza/country/cases_table_2009_09_24/en/index.html. Accessed October 8, 2009.
86. 86 Ungchusak, K., Auewarakul, P., Dowell, S.F., et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 352 (2005), 333–340.
87. 87 Wang, H., Feng, Z., Shu, Y., et al. Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet 371 (2008), 1427–1434.
88. 88 Buxton Bridges, C., Katz, J.M., Seto, W.H., et al. Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis 181 (2000), 344–348.
89. 89 Liem, N.T., Lim, W., Lack of H5N1 avian influenza transmission to hospital employees, Hanoi, 2004. Emerg Infect Dis 11 (2005), 210–215.
90. 90 Schultsz, C., Dong, V.C., Chau, N.V., et al. Avian influenza H5N1 and healthcare workers. Emerg Infect Dis 11 (2005), 1158–1159.
91. 91 Shinya, K., Ebina, M., Yamada, S., et al. Avian flu: influenza virus receptors in the human airway. Nature 440 (2006), 435–436.
92. 92 World Health Organization. Human infection with avian influenza A(H7N9) virus – China. Available at: http://www.who.int/csr/don/17-may-2016-ah7n9-china/en/. Accessed May 30, 2016.
93. 93 Fang, C.F., Ma, M.J., Zhan, B.D., et al. Nosocomial transmission of avian influenza A (H7N9) virus in China: epidemiological investigation. BMJ, 351, 2015, h5765.
94. 94 Farooqui, A., Liu, W., Kelvin, D.J., et al. Probable hospital cluster of H7N9 influenza infection. N Engl J Med 374 (2016), 596–598.
95. 95 Centers for Disease Control and Prevention. Interim guidance for infection control within healthcare settings when caring for confirmed cases, probable cases, and cases under investigation for infection with novel influenza A viruses associated with severe disease. Available at: http://www.cdc.gov/flu/avianflu/novel-flu-infection-control.htm. Accessed May 30, 2016.
96. 96 Beigel, J.H., Farrar, J., Han, A.M., et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 353 (2005), 1374–1385.
97. 97 World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Available at: http://www.who.int/csr/sars/country/table2004_04_21/en/. Accessed May 30, 2016.
98. 98 Zaki, A.M., van Boheemen, S., Bestebroer, T.M., et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367 (2012), 1814–1820.
99. 99 World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). Available at: http://www.who.int/emergencies/mers-cov/en/. Accessed May 30, 2016.
100. 100 Assiri, A., McGeer, A., Perl, T.M., et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 369 (2013), 407–416.
101. 101 Balkhy, H.H., Alenazi, T.H., Alshamrani, M.M., et al. Notes from the field: nosocomial outbreak of middle east respiratory syndrome in a large tertiary care Hospital - Riyadh, Saudi Arabia, 2015. MMWR Morb Mortal Wkly Rep 65 (2016), 163–164.
102. 102 Hunter, J.C., Nguyen, D., Aden, B., et al. Transmission of middle east respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi. Emerg Infect Dis 22 (2016), 647–656.
103. 103 Chowell, G., Abdirizak, F., Lee, S., et al. Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC Med, 13, 2015, 210.
104. 104 Hastings, D.L., Tokars, J.I., Abdel Aziz, I.Z., et al. Outbreak of middle east respiratory syndrome at tertiary care hospital, Jeddah, Saudi Arabia, 2014. Emerg Infect Dis 22 (2016), 794–801.
105. 105 Hsieh, Y.H., 2015 middle east respiratory syndrome coronavirus (MERS-CoV) nosocomial outbreak in South Korea: insights from modeling. PeerJ, 3, 2015, e1505.
106. 106 Bin, S.Y., Heo, J.Y., Song, M.S., et al. Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea. Clin Infect Dis 62 (2016), 755–760.
107. 107 Centers for Disease Control and Prevention. Interim infection prevention and control recommendations for hospitalized patients with middle east respiratory syndrome coronavirus (MERS-CoV). Available at: https://www.cdc.gov/coronavirus/mers/infection-prevention-control.html. Accessed May 30, 2016.
108. 108 Fu, C., Wang, S., Nosocomial infection control in healthcare settings: protection against emerging infectious diseases. Infect Dis Poverty, 5, 2016, 30.
109. 109 Brummitt, C.F., Cherrington, J.M., Katzenstein, D.A., et al. Nosocomial adenovirus infections: molecular epidemiology of an outbreak due to adenovirus 3a. J Infect Dis 158 (1988), 423–432.
110. 110 James, L., Vernon, M.O., Jones, R.C., et al. Outbreak of human adenovirus type 3 infection in a pediatric long-term care facility—Illinois, 2005. Clin Infect Dis 45 (2007), 416–420.
111. 111 Lessa, F.C., Gould, P.L., Pascoe, N., et al. Health care transmission of a newly emergent adenovirus serotype in health care personnel at a military hospital in Texas, 2007. J Infect Dis 200 (2009), 1759–1765.
112. 112 Gerber, S.I., Erdman, D.D., Pur, S.L., et al. Outbreak of adenovirus genome type 7d2 infection in a pediatric chronic-care facility and tertiary-care hospital. Clin Infect Dis 32 (2001), 694–700.
113. 113 Gordon, Y.J., Gordon, R.Y., Romanowski, E., et al. Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro. Ophthalmology 100 (1993), 1835–1839 [discussion: 9–40].
114. 114 Gardner, P.S., Court, S.D., Brocklebank, J.T., et al. Virus cross-infection in paediatric wards. Br Med J 2 (1973), 571–575.
115. 115 Meissner, H.C., Murray, S.A., Kiernan, M.A., et al. A simultaneous outbreak of respiratory syncytial virus and parainfluenza virus type 3 in a newborn nursery. J Pediatr 104 (1984), 680–684.
116. 116 Zambon, M., Bull, T., Sadler, C.J., et al. Molecular epidemiology of two consecutive outbreaks of parainfluenza 3 in a bone marrow transplant unit. J Clin Microbiol 36 (1998), 2289–2293.
117. 117 Brady, M.T., Evans, J., Cuartas, J., Survival and disinfection of parainfluenza viruses on environmental surfaces. Am J Infect Control 18 (1990), 18–23.
118. 118 Ansari, S.A., Springthorpe, V.S., Sattar, S.A., et al. Potential role of hands in the spread of respiratory viral infections: studies with human parainfluenza virus 3 and rhinovirus 14. J Clin Microbiol 29 (1991), 2115–2119.